Jiangsu Hengrui reported CNY6.01B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Kangmei Pharma CNY 1.22B 130.32M Jun/2026
Sh Fosun Pharma CNY 9.09B 637.86M Sep/2026
Sh Pharmaceutical CNY 69.22B 3.14B Jun/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Wuxi Apptec CNY 9.07B 580.89M Sep/2026
Zz Pientze Pharmaceu CNY 1.45B 431.06M Jun/2026